De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline

Dopamine agonists are the first-line treatment of prolactinomas. The risk of developing de novo psychiatric symptoms during dopamine agonist therapy is low. Herein, we report the case of a 42-year-old woman with a giant prolactinoma who developed a psychiatric disorder after 1 day of cabergoline the...

Descripción completa

Detalles Bibliográficos
Autores principales: Belhadj Slimane, Chayma, Oueslati, Ibtissem, Yazidi, Meriem, Kamoun, Elyes, Chihaoui, Melika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338660/
https://www.ncbi.nlm.nih.gov/pubmed/37457316
http://dx.doi.org/10.1177/11795476231186062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338660/
https://www.ncbi.nlm.nih.gov/pubmed/37457316
http://dx.doi.org/10.1177/11795476231186062

Ejemplares similares